An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica

British Journal of Rheumatology

Volumn 37, Issue 2, 1998, Pages 189-195

  Dasgupta, B ^c   Dolan, A L ^a   Panayi, G S ^a   Fernandes, L ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c Southend Health Care Trust   (United Kingdom)

Author keywords

Cumulative steroid dose; Fractures; Intramuscular methylprednisolone

Indexed keywords

METHYLPREDNISOLONE ACETATE; PREDNISOLONE; STEROID;

AGED; ARTICLE; BACKACHE; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FRACTURE; HEMATOMA; HUMAN; HYPERTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MOON FACE; MORNING STIFFNESS; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATIC POLYMYALGIA; SYMPTOM; WEIGHT GAIN;

EID: 0031902491     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.2.189     Document Type: Article

References (22)

1. Chuang TY, Hunder GG, Ilstrup DM, Jurland LT. Polymyalgia rheumatica. A 10 year epidemiological and clinical study. Ann Intern Med 1982;97:672.
2. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica: incidences of different clinical presentations and eye complications. Arthritis Rheum 1981;24:899.
3. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40:1-5.
4. Kyle V, Hazleman BL. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first 2 months of treatment. Ann Rheum Dis 1993;52:847-50.
5. Nesher G, Sonnenblick M, Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15 year survey of 43 patients. Br J Rheumatol 1994;21:1283-6.
6. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis II. Relation between steroid dose and steroid side effects. Ann Rheum Dis 1989;48:662-6.
7. Delecoeullerie D, Joly P, Cohen de Lara A, Paolaggi JB. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 1988;9:733-9.
8. Corkill MM, Kirkham BW, Chikanza IC, Gibson T, Panayi GS. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24 week randomised controlled trial. Br J Rheumatol 1990;29:274-9.
9. Dasgupta B, Gray J, Fernandes L, Olliff C. Treatment of polymyalgia rheumatica with intramuscular injections of depot methylprednisolone. Ann Rheum Dis 1991;50:942-5.
10. Adachi JD, Bensen WG, Hosman AB. Corticosteroids induced osteoporosis. Semin Arthritis Rheum 1993;22:375.
11. Morrison E, Capell H. Corticosteroids in the management of rheumatoid arthritis. Br J Rheumatol 1996;35:2-4.
12. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265.
13. Ruegesegger P, Medici TC, Anlinker M. Corticosteroid-induced bone loss: A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983;25:615.
14. Rizzato G, Tosi G, Mella C et al. Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in post menopausal women. Sarcoidosis 1988;5:93.
15. Dykman TR, Gluck OS, Murphy WA et al. Evaluation of factors associated with glucocorticoid induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361-8.
16. Adachi JD, Bensen WG, Bell MJ et al. Corticosteroids induced osteoporosis: Follow up over 3 years. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. 3rd edn. Third International Symposium on Osteoporosis. Copenhagen, Denmark: Osteopress ApS, 1990:1745-947.
17. Mateo JD, Bensen WG, Hosman AB. Corticosteroids induced osteoporosis. Semin Arthritis Rheum 1993;22:375.
18. Rich GM, Mudge GH, Laffel GL et al. Cyclosporine A and prednisolone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 1992;11:950-8.
19. Shane E, Rivas MDC, Silverberg SJ et al. Osteoporosis after cardiac transplantation. Am J Med 1993;94:257-64.
20. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
21. Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991;46:803-6.
22. Wolfe F, Mitchell DM, Sibley JT et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-96.